In an opinion issued on Monday, the High Health Authority now advises against administering the Moderna vaccine to people under 30 years of age because of a possible increased risk of myocarditis in the youngest, explains the HAS in a press release. .
The latest data available in France “confirms the risk of the occurrence of very rare cases of myocarditis with favorable evolution” after vaccination against Covid-19.
However, these cases are "five times less" in those under 30 vaccinated with Pfizer-BioNTech rather than Moderna, explains HAS.
The HAS therefore recommends vaccinating people under 30 years of age with the Pfizer-BioNTech vaccine "whether it is a primary vaccination or a booster".
Health
epidemic
Moderna
Vaccination
Covid 19
Anti-covid vaccine
Coronavirus